These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1578664)

  • 1. [Treatment of uremic patients at high bleeding risk].
    Kinugasa E; Makita T; Akizawa T; Koshikawa S
    Nihon Rinsho; 1992 Jan; 50 Suppl():118-24. PubMed ID: 1578664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of uremic patients with high bleeding risk].
    Ogata H; Kinugasa E
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():70-4. PubMed ID: 15250271
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodialysis using gabexate mesilate (FOY) in patients with a high bleeding risk.
    Taenaka N; Terada N; Takahashi H; Tachimori Y; Okada T; Takezawa J; Shimada Y; Yoshiya I
    Crit Care Med; 1986 May; 14(5):481-3. PubMed ID: 3084171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic manipulations in uremic bleeding.
    Watson AJ; Whelton A
    J Clin Pharmacol; 1985; 25(5):315-7. PubMed ID: 3928704
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of uremic bleeding.
    Couch P; Stumpf JL
    Clin Pharm; 1990 Sep; 9(9):673-81. PubMed ID: 2171866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy for uremic bleeding.
    Sloand JA
    Int J Artif Organs; 1996 Aug; 19(8):439-40. PubMed ID: 8841839
    [No Abstract]   [Full Text] [Related]  

  • 7. [Uremic neuropathy in chronic kidney failure with dialysis].
    Ogura Y; Chichihara Y
    Nihon Rinsho; 1992 Jan; 50 Suppl():824-7. PubMed ID: 1315886
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bleeding tendency in chronic kidney failure with hemodialysis].
    Takahashi H; Shibata A
    Nihon Rinsho; 1992 Jan; 50 Suppl():771-7. PubMed ID: 1578765
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based treatment recommendations for uremic bleeding.
    Hedges SJ; Dehoney SB; Hooper JS; Amanzadeh J; Busti AJ
    Nat Clin Pract Nephrol; 2007 Mar; 3(3):138-53. PubMed ID: 17322926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding disorders in uremia: pathophysiology and treatment.
    Remuzzi G
    Adv Nephrol Necker Hosp; 1989; 18():171-86. PubMed ID: 2493714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodialysis of uremic patients with a high risk of bleeding].
    Qu SL; Chen QG
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):131-3, 10. PubMed ID: 2776054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Essential amino acids supplementation therapy in uremic patients with regular dialysis treatment].
    Ando A
    Nihon Rinsho; 1991 Dec; 49 Suppl():775-80. PubMed ID: 1808349
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uremic myopathy in chronic kidney failure with dialysis].
    Ogura Y; Arizono K
    Nihon Rinsho; 1992 Jan; 50 Suppl():828-9. PubMed ID: 1533695
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimizing hemorrhagic complications in dialysis patients.
    Lohr JW; Schwab SJ
    J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic bleeding.
    Rabiner SF
    Prog Hemost Thromb; 1972; 1():233-50. PubMed ID: 4569724
    [No Abstract]   [Full Text] [Related]  

  • 19. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
    N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.